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Abstract
Background: Coronary angiography is frequently employed to aid in the diagnosis of acute coronary 
thrombosis, but there is limited data to support its efficacy. The aim of the study was to evaluate sensi-
tivity and specificity of five commonly used angiographic characteristics for diagnosis of acute coronary 
thrombosis: Ambrose complex lesion morphology; spherical, ovoid, or irregular filling defect; abrupt 
vessel cutoff; intraluminal staining; and any coronary filling defect.
Methods: Coronary angiography of 80 acute myocardial infarction or stable coronary artery disease 
subjects were assessed in blinded fashion, for the presence or absence of five angiographic characteristics. 
Only lesions of ≥ 10% stenosis were included in the analysis. Presence or absence of each angiographic 
characteristic was compared between lesions with or without the following study defined outcomes:  
1) histologically confirmed thrombus, 2) highly probable thrombus, and 3) highly unlikely thrombus.  
Results: A total of 323 lesions were evaluated. All studied angiographic characteristics were associ-
ated with histologically confirmed and highly probable thrombotic lesions vs. lesions not meeting criteria 
for these outcomes (p < 0.03), except for complex Ambrose morphology which was not associated with 
any of the study outcomes (p > 0.05). Specificity for identifying histologically confirmed or highly prob-
able thrombotic lesion was high (92–100%), especially for spherical, ovoid, or irregular filling defect 
(99–100%) and intraluminal staining (99%). Sensitivity for identification of histologically confirmed 
or highly probable thrombotic lesions was low for all tested angiographic characteristics (17–60%). 
Conclusions: The presence of spherical, ovoid, or irregular filling defect or intraluminal staining was 
highly suggestive of coronary thrombus. However, none of the evaluated angiographic characteristics 
were useful for ruling out the presence of coronary thrombus. If confirmed in an independent cohort, 
these angiographic characteristic will be of significant value in confirming the diagnosis of acute coro-
nary thrombosis. (Cardiol J 2017; 24, 1: 25–34)
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Introduction
Acute myocardial infarction (MI) remains 
a leading cause of death worldwide. It is most 
often a result of atherosclerotic plaque disruption 
(erosion or rupture), accompanied by thrombus 
formation that results in obstruction of blood 
flow, tissue ischemia and necrosis [1]. Although 
significant advancements have been made using 
biomarkers and electrocardiograms (ECGs) to di-
agnose acute MI, these methods measure the end 
result (i.e., myocardial necrosis) and not the cause 
and therapeutic target, coronary thrombosis. There 
are several common non-thrombotic causes of MI 
(e.g., demand ischemia, stress cardiomyopathy), 
with varying therapeutic and prognostic implica-
tions [2]. Hence, these measurements cannot 
distinguish tissue necrosis caused by coronary 
thrombosis from other causes of necrosis such as 
demand ischemia or stress cardiomyopathy [2]. 
Even in the most fulminant manifestation of MI, 
acute ST-elevation MI (STEMI), 14% of subjects 
have no identifiable culprit lesion on angiography 
when conservatively defined as no lesion with 
> 70% stenosis [3]. Additionally, while circulating 
levels of cardiac proteins such as cardiac troponin 
are specific indicators of myocardial necrosis, the 
levels of these proteins often do not increase for 
several hours subsequent to the initial acute MI 
delaying diagnosis [4]. Therefore, current diag-
nostic criteria for acute MI often fail to confirm 
the diagnosis prior to the induction of irreversible 
myocardial necrosis, even with highly sensitive 
cardiac troponin assays [5].
Coronary angiography remains the standard 
diagnostic tool for evaluating patients suspected 
of acute coronary thrombus. The third universal 
definition of acute MI identifies angiographic 
confirmation of coronary thrombus as a criterion 
for the diagnosis of acute MI [6]. However, there 
is limited data available concerning the sensitiv-
ity and specificity of angiography for presence or 
absence of coronary thrombus. 
The goal of the present study is to evaluate 
the utility of five commonly used angiographic 
characteristics (Ambrose complex lesion morphol-
ogy; spherical, ovoid, or irregular filling defect; 
abrupt vessel cutoff; intraluminal staining; and any 
coronary filling defect) in identifying the presence 
of an acute coronary thrombus in 80 subjects with 
acute MI or stable coronary artery disease (CAD) 
undergoing coronary angiography. 
Methods
Study design and population
Between March 2012 and September 2013, 
80 acute MI or stable CAD patients (Supplemental 
Table 1 — see journal website) undergoing coro-
nary angiography at KentuckyOne Health Jewish 
Hospital or the University of Louisville Hospital 
(Louisville, Kentucky, United States) were pro-
spectively enrolled in the study prior to coronary 
angiography. Patients who received fibrinolytic 
therapy prior to coronary angiography were not 
eligible. The study protocol was approved by the 
institutional review board and all subjects provided 
informed written consent. All ECGs were system-
atically evaluated according to established criteria 
by a single board-certified cardiologist [6–9].
Coronary angiography
Angiograms were systematically evaluated in 
all subjects by an experienced team of one techni-
cian and one board certified interventional cardiolo-
gist, blinded to all other subject data. All reported 
values represent a consensus opinion from the 
Angiographic Core Laboratory, Johns Hopkins 
University (Baltimore, Maryland). Angiographic 
scoring (Supplemental Figure 1 — see journal 
website) was developed prior to assessment, to 
include the evaluation of angiographic character-
istics reported in the literature (Supplemental 
Figure 2 — see journal website) for detection 
of a coronary thrombus [10–18]. The presence of 
following five angiographic characteristics were 
defined a priori as independent variables: 1) com-
plex Ambrose lesion morphology (Fig. 1A) [12, 19]; 
2) spherical, ovoid, or irregular intramural filling 
defect (Fig. 1B) [13]; 3) abrupt vessel cutoff with 
persistence of contrast (Fig. 1C) [16]; 4) intralumi-
nal staining (Fig. 1D) [18]; 5) any coronary filling 
defect (includes spherical, ovoid, irregular, hazy, or 
occlusive filling defects and obstructive coronary 
dissections) (Fig. 1E) [19]. Lesions may have 
one or more of the aforementioned angiographic 
characteristics. 
Determination of individual lesions 
Individual lesions were defined as lesions in 
a distinct vessel branch or separated by > 3 cm 
of normal vessel (< 10% stenosis). The most 
severe portion of the lesion was used for grading 
the lesion. All lesions with ≥ 10% stenosis were 
evaluated. Lesion numbers were recorded on the 
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basis of their location on the 29-segment coronary 
artery map (Supplemental Figure 3 — see jour-
nal website) [17]. The ramus intermedius was 
considered to be part of the left anterior descending 
coronary artery territory.
Histological and biochemical analysis
The standard of care at the enrollment sites 
was to attempt coronary aspiration thrombectomy 
when an acute coronary thrombus was suspected. 
Aspiration thrombectomy was left to the discre-
tion of the treating interventional cardiologist. 
All aspiration thrombectomy attempts were im-
mediately filtered and preserved in formalin for 
histological evaluation by a pathologist at CVPath, 
Inc. (Gaithersburg, Maryland) blinded to all other 
data. Ortho Vitros 5600 assay at the University 
of Louisville Hospital and Beckman Access as-
say at the KentuckyOne Health Jewish Hospital, 
were used to measure troponin levels and con-
firm the diagnosis of acute MI. Troponin criteria 
for outcomes are detailed in the supplement 
(Supplemental Methods, Biochemical Data — 
see journal website). 
Outcome groups
Lesions from each subject were categorized 
into three outcome groups (Table 1). Group 1 
consisted of lesions with histologically confirmed 
thrombus (£ 4 days old). Group 2 consisted of 
lesions that were highly probable to contain cor-
onary thrombus — lesions with histologically 
confirmed thrombus £ 4 days old (all lesions in 
Group 1) PLUS lesions with > 70% stenosis and 
corresponding elevated troponin and ST-segment 
elevation on the ECG in territory of the vessel. 
Group 2 was created to mitigate for the selective 
coronary aspiration thrombectomy in our cohort 
and the potential failure of aspiration thrombec-
tomy to capture an existing thrombus [20]. Group 3 
consisted of lesions highly unlikely to have 
a coronary thrombus — no histologically confirmed 
thrombus recovered, no troponin elevation AND no 
ST-segment elevation or depression on the ECG. 
Figure 1. Studied angiographic characteristics; A. Complex Ambrose morphology; B. Spherical, ovoid or irregular 
filling defect; C. Abrupt vessel cutoff; D. Intraluminal staining; E. Any coronary filling defect, which includes spherical, 
ovoid, irregular, hazy, occlusive filling defects and obstructive coronary dissections.
A B C
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Ethics statement
Informed and signed consent was obtained for 
all subjects enrolled and this study was approved by 
the University of Louisville’s Institutional Review 
Board. This submission complies with the ICMJE 
ethics and STROBE guidelines. 
Statistical analysis
The primary outcome of this study was based 
on a lesion-level analysis of angiographic charac-
teristics for the detection of thrombotic lesions. 
Frequencies, percentages, and Fisher’s exact test 
p-values are reported for comparing categorical 
characteristics between subject groups. Means, 
standard deviations, and p-values from Student 
t-test or Wilcoxon rank-sum tests (as appropriate) 
are reported for comparing continuous character-
istics between groups.
In the case of a zero-count (or very low event 
count) of characteristic(s) in the cell, an absolute 
relationship would be established between the 
characteristic(s) and the occurring group, and there-
fore the odds would not be computable [21]. Under 
these conditions, conservative odds ratio estimates 
would be generated by adding one event to the zero-
count (or very low event count) cell of the group.
Primary endpoints
The primary endpoints of this study were 
the independent association of the presence of 
angiographic characteristics with the three study-
defined outcome groups. This evaluation was 
accomplished by comparing the frequencies of 
angiographic characteristics in lesions with his-
tologically confirmed thrombus (Group 1) vs. all 
lesions without histologically confirmed thrombus 
(Not-Group 1); lesions highly probable to contain 
coronary thrombus (Group 2) vs. all lesions not 
highly probable of having a thrombus (Not-Group 2) 
and lesions highly unlikely to have a coronary 
thrombus (Group 3) vs. all lesions not highly un-
likely to have a thrombus (Not-Group 3). These 
analyses are further described in the supplement 
(Supplemental Methods, Primary Endpoints 
— see journal website). Lesions in Group 1 or 
Group 2 were considered as thrombotic lesions and 
lesions in Group 3, Not-Group 1 or Not-Group 2 
were considered as non-thrombotic lesions. 
Results
Angiograms were analyzed for all 80 subjects 
enrolled in the study. Four subjects did not have 
any lesions with ≥ 10% stenosis and therefore 
did not qualify for lesion analysis; these subjects 
had non-thrombotic MI presentations (e.g., de-
mand ischemia). Seventy-six subjects had a total of 
323 individual lesions (≥ 10% stenosis). A total of 
27 thrombus aspirations were attempted from 
distinct lesions, of which 23 (85%) were confirmed 
Table 1. Classification of coronary thrombosis outcome groups.
Study lesion types Requirements
Thrombus Peak troponin Electrocardiogram and angiogram
Group 1 
Histologically  
confirmed coronary 
thrombus
Histologically con-
firmed thrombus 
of age ≤ 4 days 
aspirated
– Thrombus aspirated from coronary  
vessel (LM, LAD, LCX, RCA  
or graft)
Group 2* 
Highly probable  
coronary thrombus
Histologically con-
firmed thrombus 
of age ≤ 4 days 
aspirated
Beckman Access assay 
“Peak” troponin level  
> 0.5 ng/mL 
Ortho Vitros 5600 assay 
“Peak” troponin level  
> 0.12 ng/mL
ST-segment elevation in territory  
of vessel (LM, LAD, LCX, RCA  
or graft) with > 70% stenosis
Group 3 
Highly unlikely to  
have a coronary  
thrombus
No histologically 
confirmed throm-
bus recovered
Beckman Access assay 
“Peak” troponin level  
< 0.04 ng/mL 
Ortho Vitros 5600 assay 
“Peak” troponin level  
< 0.035 ng/mL
No ST-segment elevation  
or depression
*Should satisfy requirements for: [Thrombus] OR [Peak Troponin, ECG and Angiogram]; LAD — left anterior descending coronary artery;  
LCX — left circumflex coronary artery; LM — left main coronary artery; RCA — right coronary artery; NA — not applicable
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as thrombus on histopathology (Group 1). Thirty 
subjects had a total of 73 lesions that qualified for 
Group 2, and 18 subjects had a total of 61 lesions that 
qualified for Group 3. The clinical characteristics of 
the subjects in this cohort are presented in Table 2.
Complex Ambrose morphology
Complex Ambrose morphology was not as-
sociated with histologically confirmed coronary 
thrombus (Group 1 vs. Not-Group 1, p > 0.5), 
highly probable coronary thrombus (Group 2 vs. 
Not-Group 2, p > 0.5), nor was the absence of com-
plex Ambrose morphology associated with absence 
of coronary thrombus (Group 3 vs. Not-Group 3, 
p > 0.5, Tables 3–5). 
Spherical, ovoid or irregular filling defect 
Spherical, ovoid, or irregular filling defect 
was present in 39% of histologically confirmed 
thrombotic lesion (Group 1) as compared to 1% of 
lesions without a histologically conformed throm-
bus (Not-Group 1) (OR = 206, 95% CI 36.5–1161, 
p < 0.0001, Table 3). Similarly, it was present 
in 14% of lesions that were highly probable for 
coronary thrombus (Group 2) as compared to 
< 1% of lesions that were not highly probable for 
coronary thrombus (Not-Group 2) (OR = 60.8, 
95% CI 3.84–961, p = 0.004, Table 4). Spherical, 
ovoid, or irregular filling defect was not present 
in any lesions classified as highly unlikely to have 
a coronary thrombus (Group 3) (Table 5). Spheri-
cal, ovoid, or irregular filling defect was 22–55% 
sensitive and 99–100% specific for histologically 
confirmed or lesions highly probable for coronary 
thrombosis (Tables 3, 4).
Abrupt vessel cutoff with persistence  
of contrast
Abrupt vessel cutoff with persistence of con-
trast was present in 61% of histologically confirmed 
thrombotic lesions (Group 1) as compared to 8% of 
lesions without a histologically confirmed throm-
bus (Not-Group 1) (OR = 18, 95% CI 6.64–49.1, 
p < 0.0001, Table 3). Abrupt vessel cutoff was 
present in 27% of lesions highly probable to have 
a thrombus (Group 2) as compared to 7% of lesions 
not highly probable for a coronary thrombus (Not-
-Group 2) (OR = 3, 95% CI 1.12–6.57, p = 0.03, 
Table 4). Abrupt vessel cutoff was present in 2% of 
lesions highly unlikely to have a coronary throm-
bus (Group 3) (Table 5). Abrupt vessel cutoff was 
32–59% sensitive and 92–94% specific for histo-
logically confirmed or lesions highly probable for 
coronary thrombus (Tables 3, 4).
Table 2. Clinical characteristics of study subjects 
(n = 76).
Characteristics Subjects with  
qualifying  
lesions*
Demographics
Males 50 (65.8%)
Medical history
Diabetes 20 (26.3%)
Hypertension 57 (75.0%)
Dyslipidemia 48 (63.2%)
Atherosclerosis 36 (47.4%)
Congestive heart failure 8 (10.5%)
Chronic renal failure 6 (7.9%)
Stroke 9 (11.8%)
ESC/ACCF/AHA/WHF acute MI 55 (72.4%)
Cardiac ischemic symptoms† 71 (94.7%)
Vitals and laboratory at enrollment
Systolic blood pressure 136.7 ± 29.1
Diastolic blood pressure 78.6 ± 21.1
Body mass index 29.2 ± 6.5
Ejection fraction 48.8 ± 14.1
ST elevation 33 (34.2%)
ST depression 14 (18.4%)
Elevated troponin‡ 50 (65.8%)
Non-elevated troponin§ 17 (22.4%)
Lesions > 50% stenosis 52 (68.4%)
Lesions > 70% stenosis 52 (68.4%)
Medications at enrollment
Aspirin 66 (86.8%)
P2Y12 Inhibitor 42 (55.3%)
Statin 34 (44.7%)
Beta-blocker 26 (34.2%)
ACCF — American College of Cardiology Foundation; AHA — 
American Heart Association; ESC — European Society of Cardio l-
ogy; MI — myocardial infarction; WHF — World Health Federation 
Atherosclerosis — myocardial infarction, coronary artery disease, 
percutaneous intervention, coronary artery bypass graft
Stroke — carotid endarterectomy, peripheral artery disease,  
aortic aneurysm
*Lesions with ≥ 10% stenosis
†Symptoms prior to cardiac catheterization — localized/radiating 
pain/discomfort; dyspnea; diaphoresis; nausea; light headedness; 
syncope
‡Elevated troponin — Ortho Vitros 5600 assay = 0.12 ng/mL and 
Beckman Access assay = 0.5 ng/mL
§Non-elevated troponin — Ortho Vitros 5600 assay £ 0.035 ng/mL 
and Beckman Access assay £ 0.04 ng/mL
Intraluminal staining
Intraluminal staining was present in 35% of 
lesions with histologically confirmed thrombus 
(Group 1) as compared to 1% of lesions without 
histologically confirmed thrombus (Not-Group 1) 
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(OR = 45, 95% CI 13.4–151, p < 0.0001, Table 3). 
Intraluminal staining was present in 12% of lesions 
highly probable for a coronary thrombus (Group 2) 
as compared to 1% of lesions not highly probable 
for a coronary thrombus (Not-Group 2) (OR = 8, 
95% CI 2.12–31.6, p = 0.002, Table 4). Intraluminal 
staining was absent in all lesions highly unlikely to 
have a coronary thrombus (Table 5). Intraluminal 
staining was 17–36% sensitive and 99% specific for 
histologically confirmed or lesions highly probable 
for coronary thrombus (Tables 3, 4).
Any coronary filling defect
Any coronary filling defect was present in 48% 
of lesions with histologically confirmed thrombus 
(Group 1) as compared to 3% of lesions without 
histologically confirmed thrombus (Not-Group 1) 
(OR = 69, 95% CI 20.4–234, p < 0.0001, Table 3). 
Any coronary filling defect was present in 19% of 
lesions highly probable for a coronary thrombus 
(Group 2) and 2% of lesions not highly probable for 
a coronary thrombus (Not-Group 2) (OR = 9, 95% 
CI 2.7–26.9, p = 0.0002, Table 4). Any coronary 
Table 3. Comparisons of thrombotic angiographic characteristics between lesions in Group 1 and  
Not-Group 1.
Characteristics Group 1 (n = 23) (histologically confirmed thrombus) vs. Not-Group 1  
(n = 300)
Group 1 
N (%)
Not-Group 1 
N (%)
GEE OR 
(95% CI)
P Sensitivity 
% (95% CI)
Specificity 
% (95% CI)
Complex Ambrose  
morphology
1 (4.4) 18 (6.0) 1.02  
(0.12, 8.74)
1.0 7 (1, 37) 93 (89, 95)
Presence of spherical, ovoid  
or irregular filling defect
9 (39.1) 2 (0.7) 206  
(36.5, 1161)
< 0.0001 55 (31, 76) 99 (97,100)
Presence of abrupt vessel cutoff 
with persistence of contrast
14 (60.9) 24 (8.0) 18.1  
(6.64, 49.1)
< 0.0001 59 (38, 77) 92 (88, 95)
Presence of intraluminal  
staining
8 (34.8) 4 (1.3) 44.9  
(13.4, 151)
< 0.0001 36 (19, 58) 99 (97, 100)
Presence of any coronary  
filling defect*
11 (47.8) 8 (2.7) 69  
(20.4, 234)
< 0.0001 60 (37, 79) 97 (95, 99)
GEE OR — generalized estimating equations-estimated odds ratio between groups; CI — confidence interval
Group 1 — individual lesions with histologically confirmed thrombus
*Any coronary filling defect includes spherical, ovoid, irregular, hazy, occlusive filling defects and obstructive coronary dissections
Table 4. Comparisons of thrombotic angiographic characteristics between lesions in Group 2 and  
Not-Group 2.
Characteristics Group 2 (n = 73) (highly probable coronary thrombus) vs. Not-Group 2  
(n = 250)
Group 2  
N (%)
Not-Group 2 
N (%)
GEE OR 
(95% CI)
P Sensitivity 
% (95% CI)
Specificity 
% (95% CI)
Complex Ambrose  
morphology
5 (6.9) 14 (5.6) 1.07  
(0.9, 1.31)
0.5 14 (8, 23) 94 (89, 96)
Presence of spherical, ovoid  
or irregular filling defect
10 (13.7) 1 (0.4) 60.8  
(3.84, 961)
0.004 22 (13, 35) 100 (96, 100)
Presence of abrupt vessel cutoff 
with persistence of contrast
20 (27.4) 18 (7.2) 2.72  
(1.12, 6.57)
0.03 32 (22, 45) 94 (89, 96)
Presence of intraluminal  
staining
9 (12.3) 3 (1.2) 8.18  
(2.12, 31.6)
0.002 17 (9, 29) 99 (97, 100)
Presence of any coronary filling 
defect*
14 (19.2) 5 (2.0) 8.53  
(2.7, 26.9)
0.0003 26 (16, 39) 98 (95, 99) 
GEE OR — generalized estimating equations-estimated odds ratio between groups; CI — confidence interval
Group 2 — individual lesions with highly probable coronary thrombus [ST elevation in territory of >70% stenosis and elevated troponin]
*Any coronary filling defect includes spherical, ovoid, irregular, hazy, occlusive filling defects and obstructive coronary dissections
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filling defect was present in 2% of lesions highly 
unlikely to have a coronary thrombus (Group 3) 
(Table 5). Any coronary filling defect was 26–60% 
sensitive and 97–98% specific for histologically 
confirmed or lesions highly probable for coronary 
thrombosis (Tables 3, 4).
Discussion
In this prospective study of 80 subjects with 
acute MI or stable CAD undergoing coronary 
angiography, there were four major findings with 
important clinical implications. First, Ambrose 
morphology failed to differentiate between throm-
botic and non-thrombotic lesions. Second, the 
remaining four characteristics (spherical, ovoid, or 
irregular filling defect; abrupt vessel cutoff; intra-
luminal staining; and any coronary filling defect) 
were consistently more common and highly specific 
(92–100%) for thrombotic vs. non-thrombotic le-
sions. Third, spherical, ovoid, or irregular filling 
defect and intraluminal staining had highest specifi-
cities (99–100%) for the presence of a thrombotic 
lesion. Fourth, spherical, ovoid, or irregular filling 
defect and intraluminal staining were present in 
< 40% of all thrombotic lesions, hence a high 
specificity (99–100%) but low sensitivity (£ 55%) 
for identifying coronary thrombus in this cohort. 
Thus, in the right clinical context, their presence 
is highly suggestive of coronary thrombus, while 
their absence does not rule out an acute coronary 
thrombus. 
Although the five characteristics evaluated 
in this study have been ubiquitous in the angio-
graphic literature for decades [12, 13, 16, 18, 19], 
validation studies against histological confirmation 
of thrombus are limited. In a post-mortem study 
of lesion morphology, Levin et al. [22], found that 
79% of lesions consistent with complex Ambrose 
lesion morphology were associated with “compli-
cated” histology, which were comprised of plaque 
rupture and or hemorrhage without thrombosis. 
However, that study was limited by the unknown 
time between death and post-mortem coronary 
angiography in addition to the fact that angiography 
differs between post-mortem and a live-beating 
heart. The association between Ambrose complex 
lesion morphology and unstable angina has been 
described [10, 12, 23–26]. Recently, Ambrose et al. 
[27] reported that there exists an association be-
tween complex morphology and thrombotic/Type 1 
MI, rather than non-thrombotic/Type 2 MI, which 
is consistent with previous reports that complex 
lesions represent ruptured atherosclerotic plaque, 
partially occlusive thrombi, or both [26]. However, 
when superior imaging modalities like angioscopy 
or intravascular ultrasound (IVUS) are used to 
validate the presence of a coronary thrombus, the 
specificity of complex Ambrose morphology for 
identification of a coronary thrombus is limited 
[28–30]. In our study, we did not find a significant 
relationship between complex Ambrose morphol-
ogy and acute coronary thrombosis (Group 1 or 
Group 2 lesions). Ambrose morphology criteria 
Table 5. Comparisons of thrombotic angiographic characteristics between lesions in Group 3 and  
Not-Group 3.
Characteristics Group 3 (n = 61) (highly-unlikely to have a coronary thrombus)  
vs. Not Group-3 (n = 262)
Group 3  
N (%)
Not-Group 3 
N (%)
GEE OR  
(95% CI)
P Sensitivity  
% (95% CI)
Specificity  
% (95% CI)
Complex Ambrose  
morphology
3 (4.9) 16 (6.1) 1.06  
(0.669, 1.69)
0.8 93 (81, 98) 8 (5, 13)
Presence of spherical, ovoid  
or irregular filling defect
0 (0.0) 11 (4.2) 1.46  
(0.817, 2.62)†
0.2 98 (87, 100) 5 (3, 9)
Presence of abrupt vessel cutoff 
with persistence of contrast
1 (1.6) 37 (14.1) 1.59  
(1.23, 2.06)
< 0.0004 97 (90, 99) 14 (10, 19)
Presence of intraluminal  
staining
0 (0.0) 12 (4.6) 1.32  
(0.803, 2.17)†
0.3 98 (87, 100) 5 (3, 8)
Presence of any coronary  
filling defect*
1 (1.6) 18 (6.9) 1.45  
(1.01, 1.98)
0.046 97 (83, 100) 7 (5, 11)
GEE OR — Generalized Estimating Equation- estimated odds ratio between groups; CI — confidence interval
Group 3 — individual lesions highly unlikely to have a coronary thrombus (no ST elevation, non-elevated troponin, no histologically confirmed 
thrombus)
*Any coronary filling defect includes spherical, ovoid, irregular, hazy, occlusive filling defects and obstructive coronary dissections
†Conservative estimate generated by adding one event to zero-count cell
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may be better suited for identifying lesions associ-
ated with myocardial ischemia [16, 29], rather than 
for confirmation of an acute coronary thrombus.
Rehr et al. [31] defined intracoronary throm-
bus as presence of abrupt vessel cutoff with con-
trast persistence and intraluminal filling defect to 
differentiate unstable angina from stable angina. 
They found that the sensitivity for detecting 
a thrombus in the unstable angina group was low 
(42%) and the specificity was moderate (83%). 
Both of these characteristics were evaluated, i.e. 
abrupt vessel cutoff with contrast persistence and 
any coronary filling defect, individually in this study 
it was found that although the sensitivity of both 
the characteristics to identify thrombotic lesions 
was also low (26–60%), their specificity to identify 
thrombotic lesions was high (92–98%). 
DeWood et al. [28] studied angiographic detec-
tion of coronary thrombus in 79 STEMI patients 
undergoing emergent surgical revascularization 
and found that 75% of patients had persistent 
angiographic intraluminal staining, and 88% of 
those with intraluminal staining had a thrombus 
recovered. These results are similar to findings in 
our study wherein intraluminal staining was pre-
sent in significantly higher number of thrombotic 
lesions (Group 1 or Group 2) than non-thrombotic 
lesions (Not-Group 1 or Not-Group 2). Mabin et al. 
[32] used the presence of intraluminal filling defect 
and intraluminal staining as key criteria for detect-
ing intracoronary thrombus in patients undergoing 
percutaneous angioplasty. In the study by Mabin et 
al. [32], out of the 15 patients angiographically di-
agnosed with an intracoronary thrombus, 11 (73%) 
were confirmed to have coronary thrombus via 
emergent surgical intervention (coronary artery 
bypass grafting). The presence of both these char-
acteristics, i.e. any filling defect and intraluminal 
staining, in the histologically confirmed thrombus 
group (Group 1) of our study was low (£ 48%). 
However, the specificity of intraluminal staining 
for thrombotic lesions (Group 1 or Group 2) was 
high (99%). 
A spherical, ovoid, or irregular filling defect 
and intraluminal staining were found almost exclu-
sively in groups with thrombotic lesions. However, 
both of these characteristics were present in fewer 
than 40% of all thrombotic lesions (Group 1 and 
Group 2), hence good specificity (99–100%) but 
poor sensitivity (£ 55%) for identifying coronary 
thrombus in the present cohort. Both of these 
characteristics were significantly associated with 
thrombotic lesion groups (Group 1 or Group 2) 
and only rarely with non-thrombotic lesion groups 
(Group 3, Not-Group 1, Not-Group 2). There-
fore, the presence of either of these angiographic 
characteristics holds great promise for aiding in 
the diagnosis of coronary thrombus and warrants 
validation in an independent cohort. On the other 
hand, their absence does not rule out coronary 
thrombus in the right clinical context.
Limitations of the study
There is no gold standard for identifying the 
presence of a coronary thrombus except near-
immediate autopsy, which is only applicable to 
a select group of patients who die shortly after 
coronary angiography. Post-mortem angiography 
is of questionable relevance. In this study, stand-
ard-of-care coronary aspiration thrombectomy 
was employed, however, the decision to perform 
thrombectomy and the ensuing technique was left 
to the discretion of the interventional cardiolo-
gist [33, 34]. Furthermore, coronary aspiration 
thrombectomy may fail to capture thrombi in some 
cases [20]. Therefore criteria was introduced for 
the diagnosis of coronary thrombus that included 
histologically confirmed thrombus (Group 1) or 
a combination of electrocardiographic (ST-segment 
elevation), biochemical (elevated troponin) and 
coronary stenosis (> 70%) criteria (Group 2). 
Other techniques available for the identification 
of thrombi that were not employed in this study 
include IVUS, optical coherence tomography, and 
angioscopy; however, these techniques are limited 
by availability, the inability to cover the entire epi-
cardial coronary circulation, and the limited amount 
(or total lack) of validation data with histologically 
confirmed thrombi [35, 36].
Finally, this was not a study of all patients 
undergoing cardiac catheterization, but rather of 
a group of select patients with acute MI or stable 
CAD. Therefore, further study is required in the 
applicability of our findings to all patients suspected 
of acute MI undergoing coronary angiography.
Conclusions
Four of the five angiographic characteristics 
evaluated in this cohort were associated with 
acute coronary thrombus, as defined by histological 
analysis or a combination of histology, ST-segment 
elevation, troponin elevation and coronary ste-
nosis. The presence of either spherical, ovoid, 
or irregular filling defect or intraluminal staining 
is highly specific (99–100%) for the presence 
of thrombotic lesions but these characteristics 
were present in < 40% of thrombotic lesions and 
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therefore are not sensitive (£ 55%) for identifying 
coronary thrombus. Validation of these findings in 
an independent cohort to establish whether these 
characteristics can be used to help establish the 
diagnosis of acute coronary thrombus in clinical 
practice is warranted. 
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